Home > Insider Trading > Filing (0001415889-24-028661)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1600620	Aurinia Pharmaceuticals Inc.	AUPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1178579	Kevin Tang	4747 Executive Dr Suite 210 San Diego CA 92121		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2024-12-05	300,000	$8.91	7,529,500	No	4	P	Indirect	By LP
Common Shares	Acquisiton	2024-12-06	400,000	$9.01	7,929,500	No	4	P	Indirect	By LP
Common Shares	Acquisiton	2024-12-09	500,000	$9.09	8,429,500	No	4	P	Indirect	By LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By LP
No	4	P	Indirect	By LP
No	4	P	Indirect	By LP

Footnotes

The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $8.74 to $8.99. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1, 3 and 4.
Tang Capital Partners, LP ("TCP") beneficially owns 7,929,500 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCP III.
These shares were purchased in multiple transactions at prices ranging from $8.89 to $9.15.
These shares were purchased in multiple transactions at prices ranging from $8.88 to $9.19.